Generation of "neoheparin" from E. coli K5 capsular polysaccharide

Journal of Medicinal Chemistry

Volumn 48, Issue 2, 2005, Pages 349-352

  Lindahl, Ulf ^a   Li, Jin Ping ^a   Kusche Gullberg, Marion ^a,g   Salmivirta, Markku ^b,h   Alaranta, Sakari ^b   Veromaa, Timo ^b   Emeis, Jef ^c   Roberts, Ian ^d   Taylor, Clare ^d   Oreste, Pasqua ^e   Zoppetti, Giorgio ^e,i   Naggi, Annamaria ^f   Torri, Giangiacomo ^f   Casu, Benito ^f  

^a UPPSALA UNIVERSITY   (Sweden)

^b Biotie Therapies Corp   (Finland)

^c TNO   (Netherlands)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e Ricerche Sperimentali Montale ^*  (Italy)

^f Istituto di Ricerche Chimiche e Biochimiche G Ronzoni   (Italy)

^g UNIVERSITY OF BERGEN   (Norway)

^h TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

ⁱ IBSA Institut Biochimique SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; BACTERIAL POLYSACCHARIDE; HEPARIN DERIVATIVE; NEOHEPARIN; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; CHEMICAL MODIFICATION; DRUG ACTIVITY; DRUG BINDING; DRUG STRUCTURE; DRUG SULFATION; DRUG SYNTHESIS; ENZYME MODIFICATION; ESCHERICHIA COLI; LARGE SCALE PRODUCTION; NONHUMAN; THROMBOEMBOLISM; VEIN THROMBOSIS;

ANIMALS; ANTICOAGULANTS; ANTITHROMBINS; CARBOHYDRATE SEQUENCE; ESCHERICHIA COLI; FIBRINOLYTIC AGENTS; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES, BACTERIAL; PROTEIN BINDING; RATS; VENOUS THROMBOSIS;

EID: 19944431905     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049812m     Document Type: Article

References (18)

1. Dahlbäck, B. Blood coagulation. Lancet 2000, 355, 1627-1632.
2. Casu, B.; Lindahl, U. Structure and biological interactions of heparin and heparan sulfate. Adv. Carbohydr. Chem. Biochem. 2001, 57, 159-206.
3. Rosenberg, R. D.; Shworak, N. W.; Liu, J.; Schwartz, J. J.; Zhang, L. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J. Clin. Invest. 1997, 100, S67-S75.
4. Petitou, M.; Herault, J. P.; Bernat, A.; Drìguez, P. A.; Duchaussoy, P.; et al. Synthesis of thrombin-inhibiting heparin mimetics without side effects [see comments]. Nature 1999, 398, 417-422.
5. Alban, S. Carbohydrates with anticoagulant and antithrombotic properties. Carbohydrates in. Drug Design; Marcel Dekker: New York, 1997; pp 209-276.
6. Kusche, M.; Hannesson, H. H.; Lindahl, U. Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions. Biochem. J. 1991, 275, 151-158.
7. Kusche, M.; Bäckström, G.; Riesenfeld, J.; Petitou, M.; Choay, J.; et al. Biosynthesis of heparin. O-Sulfation of the antithrombin-binding region. J. Biol. Chem. 1988, 263, 15474-15484.
8. Kusche, M.; Oscarsson, L.-G.; Reynertson, R.; Rodén, L.; Lindahl, U. Biosynthesis of heparin. Enzymatic sulfation of pentasaccharides. J. Biol. Chem. 1991, 266, 7400-7409.
9. Kuberan, B.; Beeler, D. L.; Lawrence, R.; Lech, M.; Rosenberg, R. D. Rapid two-step synthesis of mitrin from heparosan: a replacement for heparin. J. Am. Chem. Soc. 2003, 125, 12424-12425.
10. Kuberan, B.; Lech, M. Z.; Beeler, D. L.; Wu, Z. L.; Rosenberg, R. D. Enzymatic synthesis of antithrombin III-binding heparan sulfate pentasaccharide. Nat. Biotechnol. 2003, 21, 1343-1346.
11. Hricovini, M.; Guerrini, M.; Bisio, A.; Torri, G.; Petitou, M.; et al. Conformation of heparin pentasaccharide bound to antithrombin III. Biochem. J. 2001, 359, 265-272.
12. Li, J.-P.; Gong, F.; El Darwish, K.; Jalkanen, M.; Lindahl, U. Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate. J. Biol. Chem. 2001, 276, 20069-20077.
13. Hagner-McWhirter, A.; Lindahl, U.; Li, J.-P. Biosynthesis of heparin/heparan sulphate: mechanism of epimerization of glucuronyl C-5. Biochem. J. 2000, 347, 69-75.
14. Naggi, A.; Torri, G.; Casu, B.; Oreste, P.; Zoppetti, G.; et al. Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide. Semin. Thromb. Hemostasis 2001, 27, 437-443.
15. Casu, B.; Grazioli, G.; Razi, N.; Guerrini, M.; Naggi, A.; et al. Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5. Carbohydr. Res. 1994, 263, 271-284.
16. Rej, R. N.; Ludwig-Baxter, K. G.; Perlin, A. S. Sulfation of some chemically-modified heparins. Formation of a 3-sulfate analog of heparin. Carbohydr. Res. 1991, 210, 299-310.
17. Naggi, A.; De Cristofano, B.; Bisio, A.; Torri, G.; Casu, B. Generation of anti-factor Xa active, 3-O-sulfated glucosamine-rich sequences by controlled desulfation of oversulfated heparins. Carbohydr. Res. 2001, 330, 283-290.
18. Ogamo, A.; Metori, A.; Uchyama, H.; Nagasawa, K. Reactivity toward chemical sulfation of hydroxyl groups of heparin. Carbohydr. Res. 1989, 193, 165-172.